JPMORGAN CHASE & CO

JPM-PM

Held by 1 specialist biotech fund

1 fund opened new positions.

Share

Signal Score

1.5/10

1 fund opened new positions

●●

No recent insider activity●●

No upcoming catalysts●●

Held by 1 specialist fund●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

Driehaus CapitalNew

AI Signal

Signal Note:

Driehaus Capital (Caldwell HC sleeve), a growth-focused fund with significant biotech allocation, initiated a new position in JPMorgan Chase & Co. preferred shares (JPM-PM) — a non-biotech, fixed-income-like equity instrument.

Unlock full AI analysis — 14-day free trial

Short Interest

Shorts coveringSI declining 2 periods (-44.1%)

Short Shares

43K

Change

-44.1%

Days to Cover

0.2

Settlement

Jun 15, 2026

Short interest over 7 periods

Catalysts

No catalysts tracked.

Be first to know when this name moves

Fund buys and exits, insider activity, and catalyst alerts across 800+ biotechs — free Monday brief.

Position Details

Driehaus CapitalNEW POSITIONMay 15, 2026

Start free trialfor share counts, dollar values & AI analysis

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Also Held by These Funds

ANDG1 fund AAPL1 fund APLD1 fund CMI1 fund EQIX1 fund CUBB1 fund ESE1 fund MOD1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts:

Terms

Privacy

Disclaimer